Investigating how certain cells in the cochlea change into different types of hearing cells.
Transdifferentiation in the Cochlea
This study is exploring how certain cells in the inner ear can change from one type to another, which could help us find new ways to restore hearing, and it's especially for anyone interested in understanding more about how our hearing works.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10867448 on NIH RePORTER |
What this research studies
This research focuses on the cochlea, a part of the inner ear responsible for hearing, and examines how specific cells called inner hair cells (IHCs) can transform into outer hair cells (OHCs). The study looks at a protein called TBX2, which plays a crucial role in keeping IHCs from changing into OHCs. By using advanced techniques like ATAC-seq, researchers will analyze the genetic and epigenetic factors involved in this process. The goal is to understand the mechanisms behind cell differentiation in the cochlea, which could have implications for hearing restoration.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with hearing loss or those interested in advancements in hearing restoration therapies.
Not a fit: Patients with hearing loss due to irreversible damage to the cochlea or those who do not have the capacity for cellular regeneration may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for treating hearing loss by promoting the regeneration of functional hair cells in the cochlea.
How similar studies have performed: Other research has shown promising results in understanding cell differentiation in the cochlea, but this specific approach using TBX2 is relatively novel.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Garcia-Anoveros, Jaime — Northwestern University at Chicago
- Study coordinator: Garcia-Anoveros, Jaime
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.